Jennifer Taubert

Biography

Jennifer Taubert is Company Group Chairman, Johnson & Johnson, where she is responsible for the Janssen Pharmaceutical Companies throughout North America and Latin America. She is a member of the Corporation’s Management Committee and the Pharmaceuticals Group Operating Committee. Jennifer has been a leader in shaping Janssen’s global strategy of transformational medical innovation, successfully commercializing critical new medicines that significantly improve the lives of patients living with cancer, immune-related diseases, heart disease and diabetes, infectious diseases including HIV, and serious mental illness. She has built a portfolio that includes nine blockbuster therapies, and under her leadership Janssen has become one of the largest and fastest-growing pharmaceutical companies and a major catalyst of Johnson & Johnson’s growth. Jennifer is also recognized as a champion of diversity and inclusion, which she sees as critical to insight, innovation and business success.  

Research Interest

financial principles, Business Ethics, Business Administration